Basic information Description Hypoglycemic agents Pharmacological effects Pharmacokinetics Synthetic method Side effects Contraindications Precautions References Safety Related Supplier
Gliclazide Structure

Gliclazide

Chemical Properties

Melting point 163-169 °C (lit.)
Density  1.2205 (rough estimate)
refractive index  1.6740 (estimate)
storage temp.  2-8°C
solubility  methylene chloride: soluble
form  powder
pka 6.07±0.10(Predicted)
color  white
Merck  14,4439
InChI InChI=1S/C15H21N3O3S/c1-11-5-7-14(8-6-11)22(20,21)17-15(19)16-18-9-12-3-2-4-13(12)10-18/h5-8,12-13H,2-4,9-10H2,1H3,(H2,16,17,19)
InChIKey BOVGTQGAOIONJV-UHFFFAOYSA-N
SMILES C1(S(NC(NN2CC3CCCC3C2)=O)(=O)=O)=CC=C(C)C=C1
CAS DataBase Reference 21187-98-4(CAS DataBase Reference)
EPA Substance Registry System Benzenesulfonamide, N-[[(hexahydrocyclopenta[c]pyrrol-2(1H)-yl)amino]carbonyl]-4-methyl (21187-98-4)

Safety Information

Hazard Codes  Xn,Xi
Risk Statements  21-36/38-46-62-63
Safety Statements  25-26-36/37-53-24/25
RIDADR  3077
WGK Germany  2
RTECS  YT4500000
HS Code  29350090
Toxicity LD50 orally in mice: >3 g/kg (Duhault)

MSDS

Usage And Synthesis

Gliclazide Supplier

Gliclazide manufacturers